Global Myasthenia Gravis Disease Market Research Report 2023

Report ID: 1988682 | Published Date: Jan 2025 | No. of Page: 87 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Myasthenia Gravis Disease Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Medication
        1.2.3 Surgery
        1.2.4 Hematopoietic Stem Cell Transplantation (HSCT)
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Myasthenia Gravis Disease Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Academic Research Institutes
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Myasthenia Gravis Disease Market Perspective (2017-2028)
    2.2 Myasthenia Gravis Disease Growth Trends by Region
        2.2.1 Myasthenia Gravis Disease Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Myasthenia Gravis Disease Historic Market Size by Region (2017-2022)
        2.2.3 Myasthenia Gravis Disease Forecasted Market Size by Region (2023-2028)
    2.3 Myasthenia Gravis Disease Market Dynamics
        2.3.1 Myasthenia Gravis Disease Industry Trends
        2.3.2 Myasthenia Gravis Disease Market Drivers
        2.3.3 Myasthenia Gravis Disease Market Challenges
        2.3.4 Myasthenia Gravis Disease Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Myasthenia Gravis Disease Players by Revenue
        3.1.1 Global Top Myasthenia Gravis Disease Players by Revenue (2017-2022)
        3.1.2 Global Myasthenia Gravis Disease Revenue Market Share by Players (2017-2022)
    3.2 Global Myasthenia Gravis Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Myasthenia Gravis Disease Revenue
    3.4 Global Myasthenia Gravis Disease Market Concentration Ratio
        3.4.1 Global Myasthenia Gravis Disease Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Disease Revenue in 2021
    3.5 Myasthenia Gravis Disease Key Players Head office and Area Served
    3.6 Key Players Myasthenia Gravis Disease Product Solution and Service
    3.7 Date of Enter into Myasthenia Gravis Disease Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Myasthenia Gravis Disease Breakdown Data by Type
    4.1 Global Myasthenia Gravis Disease Historic Market Size by Type (2017-2022)
    4.2 Global Myasthenia Gravis Disease Forecasted Market Size by Type (2023-2028)
5 Myasthenia Gravis Disease Breakdown Data by Application
    5.1 Global Myasthenia Gravis Disease Historic Market Size by Application (2017-2022)
    5.2 Global Myasthenia Gravis Disease Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Myasthenia Gravis Disease Market Size (2017-2028)
    6.2 North America Myasthenia Gravis Disease Market Size by Country (2017-2022)
    6.3 North America Myasthenia Gravis Disease Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Myasthenia Gravis Disease Market Size (2017-2028)
    7.2 Europe Myasthenia Gravis Disease Market Size by Country (2017-2022)
    7.3 Europe Myasthenia Gravis Disease Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Myasthenia Gravis Disease Market Size (2017-2028)
    8.2 Asia-Pacific Myasthenia Gravis Disease Market Size by Country (2017-2022)
    8.3 Asia-Pacific Myasthenia Gravis Disease Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Myasthenia Gravis Disease Market Size (2017-2028)
    9.2 Latin America Myasthenia Gravis Disease Market Size by Country (2017-2022)
    9.3 Latin America Myasthenia Gravis Disease Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Myasthenia Gravis Disease Market Size (2017-2028)
    10.2 Middle East & Africa Myasthenia Gravis Disease Market Size by Country (2017-2022)
    10.3 Middle East & Africa Myasthenia Gravis Disease Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Bausch Health
        11.1.1 Bausch Health Company Detail
        11.1.2 Bausch Health Business Overview
        11.1.3 Bausch Health Myasthenia Gravis Disease Introduction
        11.1.4 Bausch Health Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.1.5 Bausch Health Recent Development
    11.2 Sun Pharmaceuticals Industries
        11.2.1 Sun Pharmaceuticals Industries Company Detail
        11.2.2 Sun Pharmaceuticals Industries Business Overview
        11.2.3 Sun Pharmaceuticals Industries Myasthenia Gravis Disease Introduction
        11.2.4 Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.2.5 Sun Pharmaceuticals Industries Recent Development
    11.3 Novartis Pharmaceuticals
        11.3.1 Novartis Pharmaceuticals Company Detail
        11.3.2 Novartis Pharmaceuticals Business Overview
        11.3.3 Novartis Pharmaceuticals Myasthenia Gravis Disease Introduction
        11.3.4 Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.3.5 Novartis Pharmaceuticals Recent Development
    11.4 Teva Pharmaceutical Industries
        11.4.1 Teva Pharmaceutical Industries Company Detail
        11.4.2 Teva Pharmaceutical Industries Business Overview
        11.4.3 Teva Pharmaceutical Industries Myasthenia Gravis Disease Introduction
        11.4.4 Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.4.5 Teva Pharmaceutical Industries Recent Development
    11.5 Cipla
        11.5.1 Cipla Company Detail
        11.5.2 Cipla Business Overview
        11.5.3 Cipla Myasthenia Gravis Disease Introduction
        11.5.4 Cipla Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.5.5 Cipla Recent Development
    11.6 Roche
        11.6.1 Roche Company Detail
        11.6.2 Roche Business Overview
        11.6.3 Roche Myasthenia Gravis Disease Introduction
        11.6.4 Roche Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.6.5 Roche Recent Development
    11.7 Apotex Corporation
        11.7.1 Apotex Corporation Company Detail
        11.7.2 Apotex Corporation Business Overview
        11.7.3 Apotex Corporation Myasthenia Gravis Disease Introduction
        11.7.4 Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.7.5 Apotex Corporation Recent Development
    11.8 Pfizer
        11.8.1 Pfizer Company Detail
        11.8.2 Pfizer Business Overview
        11.8.3 Pfizer Myasthenia Gravis Disease Introduction
        11.8.4 Pfizer Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.8.5 Pfizer Recent Development
    11.9 Bristol-Myers And Company
        11.9.1 Bristol-Myers And Company Company Detail
        11.9.2 Bristol-Myers And Company Business Overview
        11.9.3 Bristol-Myers And Company Myasthenia Gravis Disease Introduction
        11.9.4 Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2017-2022)
        11.9.5 Bristol-Myers And Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Myasthenia Gravis Disease Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Medication
    Table 3. Key Players of Surgery
    Table 4. Key Players of Hematopoietic Stem Cell Transplantation (HSCT)
    Table 5. Key Players of Other
    Table 6. Global Myasthenia Gravis Disease Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Myasthenia Gravis Disease Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 8. Global Myasthenia Gravis Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 9. Global Myasthenia Gravis Disease Market Share by Region (2017-2022)
    Table 10. Global Myasthenia Gravis Disease Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 11. Global Myasthenia Gravis Disease Market Share by Region (2023-2028)
    Table 12. Myasthenia Gravis Disease Market Trends
    Table 13. Myasthenia Gravis Disease Market Drivers
    Table 14. Myasthenia Gravis Disease Market Challenges
    Table 15. Myasthenia Gravis Disease Market Restraints
    Table 16. Global Myasthenia Gravis Disease Revenue by Players (2017-2022) & (US$ Million)
    Table 17. Global Myasthenia Gravis Disease Market Share by Players (2017-2022)
    Table 18. Global Top Myasthenia Gravis Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Disease as of 2021)
    Table 19. Ranking of Global Top Myasthenia Gravis Disease Companies by Revenue (US$ Million) in 2021
    Table 20. Global 5 Largest Players Market Share by Myasthenia Gravis Disease Revenue (CR5 and HHI) & (2017-2022)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Myasthenia Gravis Disease Product Solution and Service
    Table 23. Date of Enter into Myasthenia Gravis Disease Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Myasthenia Gravis Disease Market Size by Type (2017-2022) & (US$ Million)
    Table 26. Global Myasthenia Gravis Disease Revenue Market Share by Type (2017-2022)
    Table 27. Global Myasthenia Gravis Disease Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 28. Global Myasthenia Gravis Disease Revenue Market Share by Type (2023-2028)
    Table 29. Global Myasthenia Gravis Disease Market Size by Application (2017-2022) & (US$ Million)
    Table 30. Global Myasthenia Gravis Disease Revenue Market Share by Application (2017-2022)
    Table 31. Global Myasthenia Gravis Disease Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 32. Global Myasthenia Gravis Disease Revenue Market Share by Application (2023-2028)
    Table 33. North America Myasthenia Gravis Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 34. North America Myasthenia Gravis Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Europe Myasthenia Gravis Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 36. Europe Myasthenia Gravis Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Asia-Pacific Myasthenia Gravis Disease Market Size by Region (2017-2022) & (US$ Million)
    Table 38. Asia-Pacific Myasthenia Gravis Disease Market Size by Region (2023-2028) & (US$ Million)
    Table 39. Latin America Myasthenia Gravis Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Latin America Myasthenia Gravis Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Middle East & Africa Myasthenia Gravis Disease Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Middle East & Africa Myasthenia Gravis Disease Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Bausch Health Company Detail
    Table 44. Bausch Health Business Overview
    Table 45. Bausch Health Myasthenia Gravis Disease Product
    Table 46. Bausch Health Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 47. Bausch Health Recent Development
    Table 48. Sun Pharmaceuticals Industries Company Detail
    Table 49. Sun Pharmaceuticals Industries Business Overview
    Table 50. Sun Pharmaceuticals Industries Myasthenia Gravis Disease Product
    Table 51. Sun Pharmaceuticals Industries Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 52. Sun Pharmaceuticals Industries Recent Development
    Table 53. Novartis Pharmaceuticals Company Detail
    Table 54. Novartis Pharmaceuticals Business Overview
    Table 55. Novartis Pharmaceuticals Myasthenia Gravis Disease Product
    Table 56. Novartis Pharmaceuticals Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 57. Novartis Pharmaceuticals Recent Development
    Table 58. Teva Pharmaceutical Industries Company Detail
    Table 59. Teva Pharmaceutical Industries Business Overview
    Table 60. Teva Pharmaceutical Industries Myasthenia Gravis Disease Product
    Table 61. Teva Pharmaceutical Industries Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 62. Teva Pharmaceutical Industries Recent Development
    Table 63. Cipla Company Detail
    Table 64. Cipla Business Overview
    Table 65. Cipla Myasthenia Gravis Disease Product
    Table 66. Cipla Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 67. Cipla Recent Development
    Table 68. Roche Company Detail
    Table 69. Roche Business Overview
    Table 70. Roche Myasthenia Gravis Disease Product
    Table 71. Roche Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 72. Roche Recent Development
    Table 73. Apotex Corporation Company Detail
    Table 74. Apotex Corporation Business Overview
    Table 75. Apotex Corporation Myasthenia Gravis Disease Product
    Table 76. Apotex Corporation Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 77. Apotex Corporation Recent Development
    Table 78. Pfizer Company Detail
    Table 79. Pfizer Business Overview
    Table 80. Pfizer Myasthenia Gravis Disease Product
    Table 81. Pfizer Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 82. Pfizer Recent Development
    Table 83. Bristol-Myers And Company Company Detail
    Table 84. Bristol-Myers And Company Business Overview
    Table 85. Bristol-Myers And Company Myasthenia Gravis Disease Product
    Table 86. Bristol-Myers And Company Revenue in Myasthenia Gravis Disease Business (2017-2022) & (US$ Million)
    Table 87. Bristol-Myers And Company Recent Development
    Table 88. Research Programs/Design for This Report
    Table 89. Key Data Information from Secondary Sources
    Table 90. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Myasthenia Gravis Disease Market Share by Type: 2021 VS 2028
    Figure 2. Medication Features
    Figure 3. Surgery Features
    Figure 4. Hematopoietic Stem Cell Transplantation (HSCT) Features
    Figure 5. Other Features
    Figure 6. Global Myasthenia Gravis Disease Market Share by Application in 2021 & 2028
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Academic Research Institutes Case Studies
    Figure 10. Myasthenia Gravis Disease Report Years Considered
    Figure 11. Global Myasthenia Gravis Disease Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Myasthenia Gravis Disease Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Myasthenia Gravis Disease Market Share by Region: 2021 VS 2028
    Figure 14. Global Myasthenia Gravis Disease Market Share by Players in 2021
    Figure 15. Global Top Myasthenia Gravis Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis Disease as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis Disease Revenue in 2021
    Figure 17. North America Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. North America Myasthenia Gravis Disease Market Share by Country (2017-2028)
    Figure 19. United States Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Canada Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Myasthenia Gravis Disease Market Share by Country (2017-2028)
    Figure 23. Germany Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. France Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. U.K. Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Italy Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Russia Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Nordic Countries Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Myasthenia Gravis Disease Market Share by Region (2017-2028)
    Figure 31. China Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Japan Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. South Korea Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Southeast Asia Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. India Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Australia Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Myasthenia Gravis Disease Market Share by Country (2017-2028)
    Figure 39. Mexico Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Brazil Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Myasthenia Gravis Disease Market Share by Country (2017-2028)
    Figure 43. Turkey Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Saudi Arabia Myasthenia Gravis Disease Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Bausch Health Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 46. Sun Pharmaceuticals Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 47. Novartis Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 48. Teva Pharmaceutical Industries Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 49. Cipla Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 50. Roche Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 51. Apotex Corporation Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 52. Pfizer Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 53. Bristol-Myers And Company Revenue Growth Rate in Myasthenia Gravis Disease Business (2017-2022)
    Figure 54. Bottom-up and Top-down Approaches for This Report
    Figure 55. Data Triangulation
    Figure 56. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bausch Health
Sun Pharmaceuticals Industries
Novartis Pharmaceuticals
Teva Pharmaceutical Industries
Cipla
Roche
Apotex Corporation
Pfizer
Bristol-Myers And Company
Frequently Asked Questions
Myasthenia Gravis Disease report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Myasthenia Gravis Disease report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Myasthenia Gravis Disease report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Nachos

The research report includes specific segments by region (country), by company, by Type and by Sa ... Read More

Nail Polish Remover

The research report includes specific segments by region (country), by company, by Type and by Sa ... Read More

Nano GPS Chip

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More

Nano Metrology

Nano Metrology market is segmented by players, region (country), by Type and by Application. Play ... Read More